Cargando…

Role of β1 integrin and its signaling molecule, Cas-L, in pathophysiology and therapeutic interventigens of rheumatoid arthritis

Detalles Bibliográficos
Autor principal:	Morimoto, C
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833882/ http://dx.doi.org/10.1186/ar892

Ejemplares similares

Cas-L associates with human T-lymphotropic virus type I Tax and regulates its transactivation of NF-κB: possible role of Cas-L in pathophysiology of rheumatoid arthritis
por: Iwata, S, et al.
Publicado: (2003)

Clusterin, a potential pathophysiological actor in rheumatoid arthritis
por: Devauchelle, V, et al.
Publicado: (2004)

Specific contributions of H-Ras and N-Ras GTPases to T-lymphocyte oxidative stress and integrin-dependent retention in rheumatoid arthritis
por: Remans, PHJ, et al.
Publicado: (2005)

Therapeutic approach to patients with rheumatoid arthritis and chronic HBV/HCV infection
por: Daia-Iliescu, Sînziana, et al.
Publicado: (2014)

Short-fibre modification facilitates adenovirus-mediated gene delivery in rheumatoid arthritis synoviocytes and synovium: role of RGD and non-RGD binding integrins
por: Toh, M-L, et al.
Publicado: (2005)

Significance of fatigue in patients with rheumatoid arthritis
por: Singh, G, et al.
Publicado: (2003)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Collagenous colitis and rheumatoid arthritis: is there a connection?
por: Wollheim, F, et al.
Publicado: (2003)

IL-15 and its role in rheumatoid arthritis
por: Kurowska-Stolarska, M, et al.
Publicado: (2003)

The importance of cell surface RANKL in rheumatoid arthritis
por: Krystufkova, O, et al.
Publicado: (2005)

The functions of the post-translational modifications in rheumatoid arthritis
por: Aratani, Satoko, et al.
Publicado: (2012)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Circulating levels of IL-7 in rheumatoid arthritis
por: Churchman, S, et al.
Publicado: (2007)

Seronegative and seropositive rheumatoid arthritis treated with rituximab
por: Velloso Feijoo, Maria Luisa, et al.
Publicado: (2012)

Signaling pathways involved in TRAIL-induced rheumatoid arthritis synovial fibroblast proliferation
por: Morel, J, et al.
Publicado: (2005)

Therapeutic inhibition of tumour necrosis factor alpha reduces oligoclonality in the selected T-cell receptor BV families in rheumatoid arthritis
por: Pierer, M, et al.
Publicado: (2003)

Repeated B-cell depletion with rituximab in rheumatoid arthritis
por: Edwards, J, et al.
Publicado: (2003)

Pathogenetic roles of Synoviolin in synovial hyperplasia of rheumatoid arthritis
por: Yamasaki, S, et al.
Publicado: (2003)

Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003)

Genotype-dependent NOS-3 expression and rheumatoid arthritis
por: Cattaruzza, M, et al.
Publicado: (2005)

Antibodies to ferritin in rheumatoid arthritis are associated with disease severity
por: Mewar, D, et al.
Publicado: (2005)

Bone mineral density in patients with Juvenile Rheumatoid Arthritis
por: Zhizho, Ye, et al.
Publicado: (2008)

Interleukin-6 receptor in the recent-onset rheumatoid arthritis
por: Montes-Cano, Marco Antonio, et al.
Publicado: (2011)

The AIRE gene and susceptibility to rheumatoid arthritis in the Spanish population
por: Torres, Belen, et al.
Publicado: (2011)

Impaired NK and NKT cells immunobiology in rheumatoid arthritis
por: Aggarwal, Ashish, et al.
Publicado: (2012)

Extrathymic Autoimmune Regulator (AIRE) expression in rheumatoid arthritis
por: Noort, Ae-Ri, et al.
Publicado: (2012)

IL-17-producing (©)™T cells are important for the development of arthritis in a rheumatoid arthritis model
por: Akitsu, Aoi, et al.
Publicado: (2012)

IFN-β for the treatment of rheumatoid arthritis?
por: Tak, P, et al.
Publicado: (2003)

Galectin-3 and galectin-3 binding protein in rheumatoid arthritis
por: Ohshima, S, et al.
Publicado: (2003)

Integrins and their ligands in rheumatoid arthritis
por: Lowin, Torsten, et al.
Publicado: (2011)

Within-subject foot motion variability in patients with Rheumatoid Arthritis
por: Hooper, Lindsey, et al.
Publicado: (2010)

Impaired early B-cell tolerance in patients with rheumatoid arthritis
por: Samuels, J, et al.
Publicado: (2005)

PTPN22 as a rheumatoid arthritis susceptibility but not severity gene
por: Wesoly, J, et al.
Publicado: (2005)

Rheumatoid arthritis and risk factors for low bone mineral density
por: Arinoviche, R
Publicado: (2004)

Adrenal function in rheumatoid arthritis: a correlation with disease activity
por: Imrich, Richard, et al.
Publicado: (2012)

Clinical-experimental assessment of simvastatin efficiency in the treatment of rheumatoid arthritis
por: Tadjikhodjaeva, Rikhikhon N, et al.
Publicado: (2012)

Methotrexate alone and methotrexate combined with etanercept in treatment of rheumatoid arthritis
por: Rexhepi, Sylejman, et al.
Publicado: (2012)

Systemic-onset juvenile rheumatoid arthritis and ANCA-associated glomerulonephritis
por: Belot, A, et al.
Publicado: (2008)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
por: Martínez-Pérez, Rosalía, et al.
Publicado: (2011)

Unique circulating cytokine profile of rheumatoid arthritis patients with nodules
por: Hodkinson, Bridget, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tlt2bbsgcrdrg72sjs44i6l7us